Tab is Medical Director at Day One Biopharma and oversees Firefly-2, the global registrational trial of tovorafenib for pediatric low-grade glioma. Former pediatric neuro-oncologist and director of trial development for the Pacific Pediatric Neuro-Oncology Consortia, she has 7 years of academic and industry experience in design and oversight of pediatric CNS tumor trials.
